Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 25: Real-World EVOQUE Outcomes from TVT Registry
Author(s): Raj Makkar Added: 7 months ago
TCT 25 - Dr Raj Makkar (Cedars-Sinai Medical Center, US) joins us to discuss the findings on the EVOQUE Valve (Edwards Lifesciences) drawing from data in the STS/ACC Transcatheter Valve Therapy Registry.The study evaluated procedural success rates, in-hospital complications, and 30-day clinical outcomes in patients undergoing transcatheter tricuspid valve replacement for severe tricuspid… View more

Intervention
Research Area(s) / Expertise: Job title: Professor of Cardiac Surgery, and Chief, Department of Cardiac Surgery
Prof Ottavio Alfieri is Senior Consultant at the Cardiothoracic Surgery Unit of San Raffaele Hospital, Milan, IT. He is the President of the "Alfieri Heart Foundation," established to support research and innovation at San Raffaele Hospital. From 1996 to 2017, he served as the Director of the Cardiothoracic Surgery Unit at San Raffaele Hospital in Milan and held the position of Professor of… View more
NY Valves 25: Early Clinical and QoL Outcomes of the PASCAL System
Author(s): Santiago Garcia Added: 11 months ago
New York Valves 2025 - Early outcomes from an observational study with the PASCAL System show a 97% device success rate.Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss a novel TEER device system. This observational study investigated the use of the PASCAL Prescision system in over 2000 patients from the STS/ACC/TVT registry over a period of two years.Findings… View more

Intervention
Research Area(s) / Expertise: Job title: Cardiothoracic Surgeon in the Department of Cardiothoracic Surgery
A Pieter Kappetein
Research Area(s) / Expertise: Job title: Consultant Cardiothoracic Surgeon, Professor and Chair of the residency program
Dr. Pieter Kappetein, MD, PhD, is a Consultant Cardiothoracic Surgeon, Professor and Chair of the residency program at the Thoraxcenter at the Erasmus Medical Centre in Rotterdam, The Netherlands. He is board certified in Cardiothoracic Surgery. His specialty is cardiothoracic surgery. He is Secretary General of the European Association for Cardio-thoracic Surgery, President of CTSnet and member… View more
Operator Volume Linked to TAVR and MTEER Outcomes
Added: 5 months ago Source:  Radcliffe Cardiology
A new study suggests that while hospital-level associations between procedural volume and outcomes for transcatheter valve therapies may be plateauing, an operator's individual experience remains a significant factor. An analysis of a large US registry found a persistent inverse association between operator volume and patient outcomes for both transcatheter aortic valve replacement (TAVR) and… View more

Guidelines & Statements

Intervention
Joseph Bavaria
Research Area(s) / Expertise:

Vascular Disease and Surgery

 Job title: Professor of Surgery and Vice-Chief
Prof Joseph Bavaria is a Professor of Surgery and Vice-Chief, Division of Cardiovascular Surgery at the Hospital of the University of Pennsylvania, Philadelphia, US.Prof Bavaria is the STS/ACC TVT Steering Committee Chairman and the Director of the Thoracic Aortic Surgery Program at PENN (a multidisciplinary programme involving all aspects of aortic disease). View more
Transcatheter Aortic Valve Implantation Indications and Patient Selection
Author(s): Jonathan Curio , Henning Guthoff , Stephan Nienaber , et al Added: 1 year ago

Vascular Disease and Surgery
Minimalist TAVI Anaesthesia Noninferior to Standard Care
Added: 6 months ago Source:  Radcliffe Cardiology
Minimalist treatment strategies for transcatheter aortic valve implantation (TAVI) are becoming more common, but have been supported by limited data from large randomised trials.² The DOUBLE-CHOICE trial was designed to evaluate the safety and efficacy of a minimalist approach (MA) using isolated local anaesthesia compared with the standard of care (SoC) with conscious sedation for transfemoral… View more

Demographic

Guidelines & Statements
ENCIRCLE: TMVR Effective for Inoperable Mitral Regurgitation
Added: 7 months ago Source:  Radcliffe Cardiology
For patients with severe mitral regurgitation (MR) who are unsuitable for surgery or transcatheter edge-to-edge repair (TEER), therapeutic options are limited. The prospective, single-arm ENCIRCLE trial evaluated the 1-year outcomes of a novel percutaneous transseptal transcatheter mitral valve replacement (TMVR) system in this challenging patient population.¹The SAPIEN M3 system (Edwards… View more